The American Journal of Managed Care: Ixekizumab Improves Children’s Dermatology Life Quality Index Over 2 Years
Study findings show that scores on the Psoriasis Area and Severity Index and the Dermatology Quality of Life Index are correlated in patients with psoriasis across several continents, but factors ...
Patients with moderate-to-severe plaque psoriasis experienced early and sustained improvements through 108 weeks of treatment. Plaque psoriasis can greatly impact the health-related quality of life in ...
Measures of skin discoloration had a greater effect on quality of life in patients with psoriasis than overall clearance of skin lesions.
The American Journal of Managed Care: Quality of Life, Severity Scales Correlated in Patients With Psoriasis Worldwide
Sofpironium bromide in the treatment of primary axillary hyperhidrosis improves Hyperhidrosis Disease Severity Scale scores, reduces gravimetric weight of sweat, and improves Dermatology Life Quality ...
In a Danish cohort study, the frequency, severity, and duration of flares predicted worse atopic dermatitis (AD) severity and quality of life a year later. Researchers analyzed data from 878 adults ...
Medscape: Biologic Plus GLP-1 Agonist Improves Quality of Life in Psoriatic Disease
The American Journal of Managed Care: Tildrakizumab Effectively Enhances Quality of Life in Moderate to Severe Psoriasis
In a UK study, patients with psoriasis having higher levels of physical activity, adequate sleep duration, and a healthy BMI reported a reduced likelihood of quality-of-life impairments compared to ...
Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults with ...